Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-28

Clinical Trial Update: VenusP-Valve Pivotal Study (PROTEUS STUDY) [NA]

View source ↗

Summary

The VenusP-Valve pivotal PROTEUS study for treating pulmonary regurgitation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Venus MedTech (HangZhou) Inc. | Conditions: Pulmonary Regurgitation | NA | Status: RECRUITING